CN Stock MarketDetailed Quotes

603590 Beijing Konruns Pharmaceutical

Watchlist
  • 24.05
  • -0.33-1.35%
Market Closed Nov 15 15:00 CST
3.85BMarket Cap33.54P/E (TTM)

Beijing Konruns Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-10.24%646.31M
-10.16%405.02M
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
Operating revenue
-10.24%646.31M
-10.16%405.02M
20.67%199.24M
6.15%920.01M
22.46%720.04M
21.33%450.84M
5.71%165.11M
7.03%866.73M
-1.44%587.99M
-18.43%371.59M
Other operating revenue
----
-73.94%491.76K
----
-85.60%2.26M
----
-88.02%1.89M
----
-86.57%15.68M
----
-81.65%15.76M
Total operating cost
-5.54%518.43M
-8.70%317.15M
11.98%150.67M
6.36%773.68M
8.37%548.85M
9.21%347.35M
5.51%134.55M
8.14%727.45M
9.78%506.47M
-11.94%318.06M
Operating cost
-6.17%68.71M
-10.74%42.39M
27.67%22.46M
-19.90%101.05M
-14.33%73.22M
-12.44%47.49M
-17.26%17.59M
19.29%126.16M
9.24%85.48M
-1.26%54.23M
Operating tax surcharges
11.97%5.19M
14.00%3.46M
-4.88%1.33M
-9.19%5.9M
-7.54%4.64M
-15.34%3.03M
-12.96%1.4M
-25.24%6.5M
-26.06%5.01M
-31.37%3.58M
Operating expense
-6.43%322.35M
-11.75%193.75M
19.72%90.45M
11.68%472.59M
13.51%344.49M
17.42%219.53M
5.61%75.55M
8.14%423.15M
14.95%303.49M
-13.59%186.97M
Administration expense
26.96%89.28M
22.07%56.52M
26.78%26.16M
7.76%110.7M
-4.86%70.32M
-3.12%46.3M
-0.16%20.64M
16.66%102.72M
15.93%73.91M
11.83%47.79M
Financial expense
80.69%-2.13M
75.66%-2.26M
43.70%-1.05M
35.84%-11.46M
31.54%-11.03M
8.53%-9.29M
56.33%-1.87M
23.65%-17.86M
10.01%-16.12M
16.55%-10.15M
-Interest expense (Financial expense)
255.98%4.38M
328.56%2.64M
314.84%1.23M
221.89%2.78M
117.45%1.23M
55.42%615.48K
42.45%297.32K
-38.66%864.06K
-46.15%565.22K
-50.95%396.02K
-Interest Income (Financial expense)
4.55%-9.56M
7.47%-6.36M
9.92%-2.92M
25.63%-13.77M
31.38%-10.02M
29.82%-6.87M
28.90%-3.24M
24.65%-18.52M
22.75%-14.59M
22.72%-9.79M
Research and development
-47.87%35.04M
-42.18%23.29M
-46.72%11.32M
9.38%94.91M
22.87%67.22M
13.01%40.29M
26.98%21.24M
-15.15%86.78M
-17.66%54.71M
-34.08%35.65M
Credit Impairment Loss
71.98%-585.17K
-124.61%-180.06K
-100.30%-4.22K
-232.40%-7.25M
-317.39%-2.09M
-117.11%-80.17K
-31.28%1.39M
-578.90%-2.18M
161.26%960.72K
127.83%468.43K
Asset Impairment Loss
----
----
----
-161.49%-11.91M
----
----
----
---4.56M
----
----
Other net revenue
-4.70%16.52M
-23.90%13.05M
-67.86%1.7M
-313.40%-3.04M
-59.93%17.34M
-60.60%17.15M
-79.49%5.28M
-97.41%1.43M
87.07%43.26M
141.92%43.54M
Fair value change income
197.48%1.6M
153.15%923.48K
100.59%1.05M
86.81%-866.8K
-1,337.16%-1.64M
---1.74M
-20.09%522.45K
-115.76%-6.57M
--132.62K
----
Invest income
13.15%12.2M
-0.53%10.11M
-138.89%-536.93K
616.30%5.56M
-61.86%10.78M
-65.16%10.16M
-93.57%1.38M
82.17%-1.08M
326.71%28.27M
315.12%29.18M
-Including: Investment income associates
78.42%-409.16K
-20.72%-1.22M
-91.44%-657.01K
7.20%-8.79M
-109.38%-1.9M
-104.77%-1.01M
-101.60%-343.2K
-225.96%-9.47M
1,502.43%20.22M
2,132.89%21.12M
Asset deal income
---7.33K
----
----
---8.23K
----
----
----
----
----
----
Other revenue
-67.78%3.31M
-75.01%2.2M
-40.15%1.19M
-27.69%11.43M
-26.02%10.28M
-36.61%8.81M
25.91%1.99M
-17.07%15.81M
-23.09%13.9M
9.82%13.9M
Operating profit
-23.40%144.4M
-16.33%100.93M
40.27%50.26M
1.83%143.28M
51.09%188.53M
24.28%120.64M
-34.14%35.83M
-26.83%140.7M
-21.22%124.78M
-13.63%97.07M
Add:Non operating Income
-99.48%1.34K
-98.29%978.72
-99.11%444.93
-48.38%261.5K
-49.07%257.56K
1,201.68%57.38K
2,292.92%50.19K
-87.64%506.62K
9,282.50%505.72K
203.60%4.41K
Less:Non operating expense
-81.11%190.5K
-83.91%129.65K
-100.00%26.66
2,229.06%20.81M
58.03%1.01M
238.14%805.78K
1,194.09%802.24K
-88.14%893.56K
19.52%638.3K
1,705.46%238.3K
Total profit
-23.20%144.21M
-15.92%100.8M
43.28%50.26M
-12.53%122.73M
50.64%187.77M
23.81%119.89M
-35.45%35.08M
-25.70%140.32M
-21.04%124.65M
-13.82%96.83M
Less:Income tax cost
-17.03%20.69M
-18.12%13.52M
-34.48%3.42M
-494.83%-64.84M
146.32%24.94M
135.22%16.52M
33.49%5.22M
-23.32%16.42M
-35.07%10.12M
-43.12%7.02M
Net profit
-24.14%123.52M
-15.57%87.28M
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
Net profit from continuing operation
-24.14%123.52M
-15.57%87.28M
56.86%46.85M
51.40%187.57M
42.19%162.84M
15.10%103.37M
-40.79%29.86M
-26.01%123.89M
-19.50%114.52M
-10.21%89.81M
Less:Minority Profit
-25.75%10.55M
-22.95%8.08M
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
114.69%10.85M
2,606,814.58%7.77M
Net profit of parent company owners
-23.99%112.98M
-14.73%79.2M
62.28%41.65M
48.24%150.45M
43.37%148.63M
13.23%92.89M
-44.72%25.67M
-31.42%101.49M
-24.45%103.67M
-17.98%82.04M
Earning per share
Basic earning per share
-24.31%0.7189
-15.25%0.5
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
Diluted earning per share
-24.31%0.7189
-15.25%0.5
68.75%0.27
47.69%0.96
43.37%0.9498
13.46%0.59
-46.67%0.16
-30.85%0.65
-23.88%0.6625
-17.46%0.52
Other composite income
12.83%51.6M
-80.19%18.88M
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.78%-57.58M
72.80%-41.31M
Other composite income of parent company owners
12.83%51.6M
-80.19%18.88M
-53.15%38.11M
125.51%6.3M
179.41%45.73M
330.76%95.33M
524.86%81.34M
85.60%-24.69M
68.16%-57.58M
72.80%-41.31M
Total composite income
-16.04%175.12M
-46.57%106.16M
-23.60%84.95M
95.43%193.87M
266.26%208.57M
309.68%198.7M
255.34%111.2M
2,567.29%99.2M
235.09%56.94M
193.52%48.5M
Total composite income of parent company owners
-15.33%164.57M
-47.89%98.08M
-25.46%79.76M
104.11%156.75M
321.70%194.36M
362.13%188.22M
292.09%107.01M
427.13%76.8M
205.58%46.09M
178.53%40.73M
Total composite income of minority owners
-25.75%10.55M
-22.95%8.08M
23.72%5.19M
65.68%37.12M
30.87%14.21M
34.88%10.48M
4.80%4.2M
15.16%22.4M
623.40%10.85M
2,606,814.58%7.77M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -10.24%646.31M-10.16%405.02M20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M
Operating revenue -10.24%646.31M-10.16%405.02M20.67%199.24M6.15%920.01M22.46%720.04M21.33%450.84M5.71%165.11M7.03%866.73M-1.44%587.99M-18.43%371.59M
Other operating revenue -----73.94%491.76K-----85.60%2.26M-----88.02%1.89M-----86.57%15.68M-----81.65%15.76M
Total operating cost -5.54%518.43M-8.70%317.15M11.98%150.67M6.36%773.68M8.37%548.85M9.21%347.35M5.51%134.55M8.14%727.45M9.78%506.47M-11.94%318.06M
Operating cost -6.17%68.71M-10.74%42.39M27.67%22.46M-19.90%101.05M-14.33%73.22M-12.44%47.49M-17.26%17.59M19.29%126.16M9.24%85.48M-1.26%54.23M
Operating tax surcharges 11.97%5.19M14.00%3.46M-4.88%1.33M-9.19%5.9M-7.54%4.64M-15.34%3.03M-12.96%1.4M-25.24%6.5M-26.06%5.01M-31.37%3.58M
Operating expense -6.43%322.35M-11.75%193.75M19.72%90.45M11.68%472.59M13.51%344.49M17.42%219.53M5.61%75.55M8.14%423.15M14.95%303.49M-13.59%186.97M
Administration expense 26.96%89.28M22.07%56.52M26.78%26.16M7.76%110.7M-4.86%70.32M-3.12%46.3M-0.16%20.64M16.66%102.72M15.93%73.91M11.83%47.79M
Financial expense 80.69%-2.13M75.66%-2.26M43.70%-1.05M35.84%-11.46M31.54%-11.03M8.53%-9.29M56.33%-1.87M23.65%-17.86M10.01%-16.12M16.55%-10.15M
-Interest expense (Financial expense) 255.98%4.38M328.56%2.64M314.84%1.23M221.89%2.78M117.45%1.23M55.42%615.48K42.45%297.32K-38.66%864.06K-46.15%565.22K-50.95%396.02K
-Interest Income (Financial expense) 4.55%-9.56M7.47%-6.36M9.92%-2.92M25.63%-13.77M31.38%-10.02M29.82%-6.87M28.90%-3.24M24.65%-18.52M22.75%-14.59M22.72%-9.79M
Research and development -47.87%35.04M-42.18%23.29M-46.72%11.32M9.38%94.91M22.87%67.22M13.01%40.29M26.98%21.24M-15.15%86.78M-17.66%54.71M-34.08%35.65M
Credit Impairment Loss 71.98%-585.17K-124.61%-180.06K-100.30%-4.22K-232.40%-7.25M-317.39%-2.09M-117.11%-80.17K-31.28%1.39M-578.90%-2.18M161.26%960.72K127.83%468.43K
Asset Impairment Loss -------------161.49%-11.91M---------------4.56M--------
Other net revenue -4.70%16.52M-23.90%13.05M-67.86%1.7M-313.40%-3.04M-59.93%17.34M-60.60%17.15M-79.49%5.28M-97.41%1.43M87.07%43.26M141.92%43.54M
Fair value change income 197.48%1.6M153.15%923.48K100.59%1.05M86.81%-866.8K-1,337.16%-1.64M---1.74M-20.09%522.45K-115.76%-6.57M--132.62K----
Invest income 13.15%12.2M-0.53%10.11M-138.89%-536.93K616.30%5.56M-61.86%10.78M-65.16%10.16M-93.57%1.38M82.17%-1.08M326.71%28.27M315.12%29.18M
-Including: Investment income associates 78.42%-409.16K-20.72%-1.22M-91.44%-657.01K7.20%-8.79M-109.38%-1.9M-104.77%-1.01M-101.60%-343.2K-225.96%-9.47M1,502.43%20.22M2,132.89%21.12M
Asset deal income ---7.33K-----------8.23K------------------------
Other revenue -67.78%3.31M-75.01%2.2M-40.15%1.19M-27.69%11.43M-26.02%10.28M-36.61%8.81M25.91%1.99M-17.07%15.81M-23.09%13.9M9.82%13.9M
Operating profit -23.40%144.4M-16.33%100.93M40.27%50.26M1.83%143.28M51.09%188.53M24.28%120.64M-34.14%35.83M-26.83%140.7M-21.22%124.78M-13.63%97.07M
Add:Non operating Income -99.48%1.34K-98.29%978.72-99.11%444.93-48.38%261.5K-49.07%257.56K1,201.68%57.38K2,292.92%50.19K-87.64%506.62K9,282.50%505.72K203.60%4.41K
Less:Non operating expense -81.11%190.5K-83.91%129.65K-100.00%26.662,229.06%20.81M58.03%1.01M238.14%805.78K1,194.09%802.24K-88.14%893.56K19.52%638.3K1,705.46%238.3K
Total profit -23.20%144.21M-15.92%100.8M43.28%50.26M-12.53%122.73M50.64%187.77M23.81%119.89M-35.45%35.08M-25.70%140.32M-21.04%124.65M-13.82%96.83M
Less:Income tax cost -17.03%20.69M-18.12%13.52M-34.48%3.42M-494.83%-64.84M146.32%24.94M135.22%16.52M33.49%5.22M-23.32%16.42M-35.07%10.12M-43.12%7.02M
Net profit -24.14%123.52M-15.57%87.28M56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M
Net profit from continuing operation -24.14%123.52M-15.57%87.28M56.86%46.85M51.40%187.57M42.19%162.84M15.10%103.37M-40.79%29.86M-26.01%123.89M-19.50%114.52M-10.21%89.81M
Less:Minority Profit -25.75%10.55M-22.95%8.08M23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M114.69%10.85M2,606,814.58%7.77M
Net profit of parent company owners -23.99%112.98M-14.73%79.2M62.28%41.65M48.24%150.45M43.37%148.63M13.23%92.89M-44.72%25.67M-31.42%101.49M-24.45%103.67M-17.98%82.04M
Earning per share
Basic earning per share -24.31%0.7189-15.25%0.568.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52
Diluted earning per share -24.31%0.7189-15.25%0.568.75%0.2747.69%0.9643.37%0.949813.46%0.59-46.67%0.16-30.85%0.65-23.88%0.6625-17.46%0.52
Other composite income 12.83%51.6M-80.19%18.88M-53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.78%-57.58M72.80%-41.31M
Other composite income of parent company owners 12.83%51.6M-80.19%18.88M-53.15%38.11M125.51%6.3M179.41%45.73M330.76%95.33M524.86%81.34M85.60%-24.69M68.16%-57.58M72.80%-41.31M
Total composite income -16.04%175.12M-46.57%106.16M-23.60%84.95M95.43%193.87M266.26%208.57M309.68%198.7M255.34%111.2M2,567.29%99.2M235.09%56.94M193.52%48.5M
Total composite income of parent company owners -15.33%164.57M-47.89%98.08M-25.46%79.76M104.11%156.75M321.70%194.36M362.13%188.22M292.09%107.01M427.13%76.8M205.58%46.09M178.53%40.73M
Total composite income of minority owners -25.75%10.55M-22.95%8.08M23.72%5.19M65.68%37.12M30.87%14.21M34.88%10.48M4.80%4.2M15.16%22.4M623.40%10.85M2,606,814.58%7.77M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Huaxing Certified Public Accountants Firm (Special General Partnership)------Huaxing Certified Public Accountants Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data